Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Mahler

Showing results (131-140 of 202) with videos related to

Pageof 21
Sort By:
Rheumatology (Oxford, England)|November 29, 2015
Anti-carbamylated protein antibodies in patients with ageing associated inflammatory chronic disordersMarcos López-Hoyos, Lorena Álvarez-Rodríguez, Michael Mahler, et al.
Plos One|April 8, 2014
Clinical and serological features of patients referred through a rheumatology triage system because of positive antinuclear antibodiesChristie Fitch-Rogalsky, Whitney Steber, Michael Mahler, et al.
The Journal of Rheumatology|February 3, 2015
Clinical and serological analysis of patients with positive anticyclic citrullinated Peptide antibodies referred through a Rheumatology Central Triage SystemLiam Martin, Whitney A Steber, Terri L Lupton, et al.
Clinical Reviews in Allergy & Immunology|January 25, 2013
Presence of anti-proteinase 3 antineutrophil cytoplasmic antibodies (anti-PR3 ANCA) as serologic markers in inflammatory bowel diseaseMaria Teresa Arias-Loste, Geovana Bonilla, Irene Moraleja, et al.
Annals of the Rheumatic Diseases|May 12, 2019
Antinuclear antibodies by indirect immunofluorescence and solid phase assaysXavier Bossuyt, Jolien Claessens, Ellen De Langhe, et al.
Thrombosis Research|April 2, 2021
Improving the clinical accuracy in patients with antiphospholipid antibodies using anti-phosphatidylserine/prothrombin and anti-beta2 glycoprotein I domain and particle-based multi-analyte technologyMassimo Radin, Silvia Foddai, Irene Cecchi, et al.
Autoimmunity Reviews|June 20, 2020
Autoantibodies to stratify systemic sclerosis patients into clinically actionable subsetsMichael Mahler, Marie Hudson, Chelsea Bentow, et al.
Autoimmunity Reviews|March 13, 2018
Solid phase assays versus automated indirect immunofluorescence for detection of antinuclear antibodiesJolien Claessens, Thibaut Belmondo, Ellen De Langhe, et al.
The American Journal of Gastroenterology|May 30, 2020
Novel Anti-Hexokinase 1 Antibodies Are Associated With Poor Prognosis in Patients With Primary Biliary CholangitisAnna Reig, Gary L Norman, Mila Garcia, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 29, 2013
PR3-ANCA: a promising biomarker for ulcerative colitis with extensive diseaseMichael Mahler, Dimitrios P Bogdanos, Polychronis Pavlidis, et al.
Pageof 21

Showing results (131-140 of 202) with videos related to

Sort By:
Pageof 21
Rheumatology (Oxford, England)|November 29, 2015
Anti-carbamylated protein antibodies in patients with ageing associated inflammatory chronic disordersMarcos López-Hoyos, Lorena Álvarez-Rodríguez, Michael Mahler, et al.
Plos One|April 8, 2014
Clinical and serological features of patients referred through a rheumatology triage system because of positive antinuclear antibodiesChristie Fitch-Rogalsky, Whitney Steber, Michael Mahler, et al.
The Journal of Rheumatology|February 3, 2015
Clinical and serological analysis of patients with positive anticyclic citrullinated Peptide antibodies referred through a Rheumatology Central Triage SystemLiam Martin, Whitney A Steber, Terri L Lupton, et al.
Clinical Reviews in Allergy & Immunology|January 25, 2013
Presence of anti-proteinase 3 antineutrophil cytoplasmic antibodies (anti-PR3 ANCA) as serologic markers in inflammatory bowel diseaseMaria Teresa Arias-Loste, Geovana Bonilla, Irene Moraleja, et al.
Annals of the Rheumatic Diseases|May 12, 2019
Antinuclear antibodies by indirect immunofluorescence and solid phase assaysXavier Bossuyt, Jolien Claessens, Ellen De Langhe, et al.
Thrombosis Research|April 2, 2021
Improving the clinical accuracy in patients with antiphospholipid antibodies using anti-phosphatidylserine/prothrombin and anti-beta2 glycoprotein I domain and particle-based multi-analyte technologyMassimo Radin, Silvia Foddai, Irene Cecchi, et al.
Autoimmunity Reviews|June 20, 2020
Autoantibodies to stratify systemic sclerosis patients into clinically actionable subsetsMichael Mahler, Marie Hudson, Chelsea Bentow, et al.
Autoimmunity Reviews|March 13, 2018
Solid phase assays versus automated indirect immunofluorescence for detection of antinuclear antibodiesJolien Claessens, Thibaut Belmondo, Ellen De Langhe, et al.
The American Journal of Gastroenterology|May 30, 2020
Novel Anti-Hexokinase 1 Antibodies Are Associated With Poor Prognosis in Patients With Primary Biliary CholangitisAnna Reig, Gary L Norman, Mila Garcia, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 29, 2013
PR3-ANCA: a promising biomarker for ulcerative colitis with extensive diseaseMichael Mahler, Dimitrios P Bogdanos, Polychronis Pavlidis, et al.
Pageof 21